Hydrocortisone And Acetic Acid Otic Solution, Usp

Hydrocortisone And Acetic Acid Otic Solution, Usp
SPL v3
SPL
SPL Set ID d9a3597c-2c9d-46cc-818b-8bb3aa5c4f32
Route
AURICULAR (OTIC)
Published
Effective Date 2024-12-06
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Acetic Acid (20.75 mg) Hydrocortisone (10.375 mg)
Inactive Ingredients
Benzethonium Chloride Propylene Glycol Propylene Glycol Diacetate Sodium Acetate Anhydrous Citric Acid

Identifiers & Packaging

Marketing Status
NDA AUTHORIZED GENERIC Active Since 2024-02-23

Description

DESCRIPTION: Hydrocortisone and Acetic Acid Otic Solution, USP is a solution containing hydrocortisone (1%) and acetic acid (2%), in a propylene glycol vehicle containing benzethonium chloride (0.02%), citric acid (0.05%), propylene glycol diacetate (3%) and sodium acetate (0.015%). The empirical formulas for acetic acid and hydrocortisone are CH3COOH, and C21H30O5, with a molecular weight of 60.05 and 362.46, respectively. The structural formulas are: Hydrocortisone and Acetic Acid is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.


Medication Information

Warnings and Precautions

WARNINGS:Discontinue promptly if sensitization or irritation occurs.

Indications and Usage

INDICATIONS AND USAGE:For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.

Dosage and Administration

DOSAGE AND ADMINISTRATION:Carefully remove all cerumen and debris to allow Hydrocortisone and Acetic Acid to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with Hydrocortisone and Acetic Acid into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of Hydrocortisone and Acetic Acid every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of Hydrocortisone and Acetic Acid 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.

Dosage Forms and Strengths

HOW SUPPLIED:Hydrocortisone and Acetic Acid Otic Solution, USP, containing hydrocortisone (1%) and acetic acid (2%), is available in 10 mL, measured-drop, safety-tip plastic bottles (NDC 71656-064-10).

Contraindications

CONTRAINDICATIONS:Hypersensitivity to Hydrocortisone and Acetic Acid or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

Description

DESCRIPTION:Hydrocortisone and Acetic Acid Otic Solution, USP is a solution containing hydrocortisone (1%) and acetic acid (2%), in a propylene glycol vehicle containing benzethonium chloride (0.02%), citric acid (0.05%), propylene glycol diacetate (3%) and sodium acetate (0.015%). The empirical formulas for acetic acid and hydrocortisone are CH3COOH, and C21H30O5, with a molecular weight of 60.05 and 362.46, respectively. The structural formulas are:

Hydrocortisone and Acetic Acid is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.

Section 34081-0

PEDIATRIC USE:Safety and effectiveness in pediatric patients below the age of 3 years have not been established.

Section 34084-4

ADVERSE REACTIONS:Stinging or burning may be noted occasionally; local irritation has occurred very rarely.

To report SUSPECTED ADVERSE REACTIONS, contact Saptalis Pharmaceuticals, LLC at 1-833-727-8254 or FDA at 1-­800-FDA-1088 or www.fda.gov/medwatch.

Section 34090-1

CLINICAL PHARMACOLOGY:Acetic acid is antibacterial and antifungal; hydrocortisone is antiinflammatory, antiallergic and antipruritic; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.

Section 42229-5

STORAGE:Store at room temperature, 20°C to 25°C (68°F to 77°F). Keep container tightly closed.

Rx only

Distributed by:

Saptalis Pharmaceuticals, LLC.

Hauppauge, NY 11788

MADE IN USA

May 2024-R3

PPM-0082

Section 42232-9

PRECAUTIONS: Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.

Package/label Principal Display Panel

NDC 71656-064-10

Hydrocortisone and Acetic Acid Otic Solution, USP

1% / 2%

For Otic Use Only

Rx only

10 mL


Structured Label Content

Indications and Usage (34067-9)

INDICATIONS AND USAGE:For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.

Dosage and Administration (34068-7)

DOSAGE AND ADMINISTRATION:Carefully remove all cerumen and debris to allow Hydrocortisone and Acetic Acid to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with Hydrocortisone and Acetic Acid into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of Hydrocortisone and Acetic Acid every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of Hydrocortisone and Acetic Acid 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.

Dosage Forms and Strengths (34069-5)

HOW SUPPLIED:Hydrocortisone and Acetic Acid Otic Solution, USP, containing hydrocortisone (1%) and acetic acid (2%), is available in 10 mL, measured-drop, safety-tip plastic bottles (NDC 71656-064-10).

Contraindications (34070-3)

CONTRAINDICATIONS:Hypersensitivity to Hydrocortisone and Acetic Acid or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

Warnings and Precautions (34071-1)

WARNINGS:Discontinue promptly if sensitization or irritation occurs.

Section 34081-0 (34081-0)

PEDIATRIC USE:Safety and effectiveness in pediatric patients below the age of 3 years have not been established.

Section 34084-4 (34084-4)

ADVERSE REACTIONS:Stinging or burning may be noted occasionally; local irritation has occurred very rarely.

To report SUSPECTED ADVERSE REACTIONS, contact Saptalis Pharmaceuticals, LLC at 1-833-727-8254 or FDA at 1-­800-FDA-1088 or www.fda.gov/medwatch.

Description (34089-3)

DESCRIPTION:Hydrocortisone and Acetic Acid Otic Solution, USP is a solution containing hydrocortisone (1%) and acetic acid (2%), in a propylene glycol vehicle containing benzethonium chloride (0.02%), citric acid (0.05%), propylene glycol diacetate (3%) and sodium acetate (0.015%). The empirical formulas for acetic acid and hydrocortisone are CH3COOH, and C21H30O5, with a molecular weight of 60.05 and 362.46, respectively. The structural formulas are:

Hydrocortisone and Acetic Acid is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.

Section 34090-1 (34090-1)

CLINICAL PHARMACOLOGY:Acetic acid is antibacterial and antifungal; hydrocortisone is antiinflammatory, antiallergic and antipruritic; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.

Section 42229-5 (42229-5)

STORAGE:Store at room temperature, 20°C to 25°C (68°F to 77°F). Keep container tightly closed.

Rx only

Distributed by:

Saptalis Pharmaceuticals, LLC.

Hauppauge, NY 11788

MADE IN USA

May 2024-R3

PPM-0082

Section 42232-9 (42232-9)

PRECAUTIONS: Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.

Package/label Principal Display Panel (PACKAGE/LABEL PRINCIPAL DISPLAY PANEL)

NDC 71656-064-10

Hydrocortisone and Acetic Acid Otic Solution, USP

1% / 2%

For Otic Use Only

Rx only

10 mL


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)